Risedronate (HMR4003)

DRUG3 trials

Sponsors

Sanofi

Conditions

Osteoporosis PostmenopausalOsteoporosis, Postmenopausal

Phase 3

Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women

CompletedNCT00353080

SanofiOsteoporosis, Postmenopausal

Start: 2002-12-31End: 2005-04-30Updated: 2009-12-15

Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women

CompletedNCT00358176

SanofiOsteoporosis Postmenopausal

Start: 2004-07-31End: 2007-03-31Updated: 2009-12-15

Phase 4

Risedronate in the Prevention of Osteoporosis in Postmenopausal Women

CompletedNCT00402441

SanofiOsteoporosis, Postmenopausal

Start: 2002-09-30End: 2004-06-30Updated: 2009-04-29